Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
InventHelp Inventor Develops New Therapeutic Tool (TRO-1644)
17 Jul 2026
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
GlobeNewswire
Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program
17 Jul 2026
PR Newswire Association LLC.
Creative Life Science Advances PIC/S GMP-Compliant Cell Therapy Materials and Manufacturing Platform
17 Jul 2026
GlobeNewswire
BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland
17 Jul 2026
GlobeNewswire
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
17 Jul 2026
GlobeNewswire
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
17 Jul 2026
PR Newswire Association LLC.
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad
17 Jul 2026
GlobeNewswire
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
16 Jul 2026
PR Newswire Association LLC.
Historic Step for Alzheimer's Care in Canada: CDA-AMC Recognizes Clinical Value of LEQEMBI® (lecanemab) and Recommends Public Coverage for Early Alzheimer's Disease
16 Jul 2026
PR Newswire Association LLC.
PRINCIPAL TECHNOLOGIES ANNOUNCES PRIVATE PLACEMENT FINANCING IN CONNECTION WITH OXFORD LICENCE AGREEMENT
16 Jul 2026
PR Newswire Association LLC.
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development, Upcoming Webinar Hosted by Xtalks
16 Jul 2026
GlobeNewswire
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
16 Jul 2026
PR Newswire Association LLC.
Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
16 Jul 2026
PR Newswire Association LLC.
Standardizing Immune-Related AE Management in Global Oncology Trials, Upcoming Webinar Hosted by Xtalks
16 Jul 2026
PR Newswire Association LLC.
Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
16 Jul 2026
GlobeNewswire
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
16 Jul 2026
GlobeNewswire
Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
16 Jul 2026
PR Newswire Association LLC.
Fairville and NRGene Canada Launch FairGene BSF Egg Facility in Alberta
16 Jul 2026
PR Newswire Association LLC.
No emergency fund? RBC poll finds over 40% of Canadians worry even one major unexpected expense could derail their finances
16 Jul 2026
GlobeNewswire
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
16 Jul 2026
GlobeNewswire
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
16 Jul 2026
PR Newswire Association LLC.
Intiveo Publishes the Most Comprehensive Benchmark Report for Dental and Oral Surgery Practices
15 Jul 2026
PR Newswire Association LLC.
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
15 Jul 2026
Upcoming Events All Events
- July 2026
- Taipei: BIO Asia-Taiwan
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum